Thin Film Drugs Market Growth, Top Key Players, Trend, Opportunities Forecast to 2027

 The global thin film drugs market size is projected to reach USD 16.27 billion in 2028. Fortune Business Insights™ published this information in a new study, titled, “Thin Film Drugs Market, 2021-2028.” The study further mentions that the market stood at USD 7.35 billion in 2020. It is expected to showcase a CAGR of 10.5% in the forecast period between 2021-2028. The surging geriatric population across the globe is anticipated to affect growth positively. As per the United Nations, in 2017, the global old age population was 962 million. It is estimated to double by the end of 2050 and reach 2.1 billion. Hence, the prevalence of Alzheimer’s and Parkinson’s diseases will also increase rapidly, thereby accelerating the demand for thin film drugs.

please visit: https://www.fortunebusinessinsights.com/thin-film-drugs-market-104883

Fortune Business Insights™ listed the names of prominent thin film drug providers present in the global market. They are as follows:

  • Pfizer, Inc.(U.S.)
  • Allergan (Ireland)
  • ZIM Laboratories Limited (India)
  • Novartis AG (Switzerland)
  • Aquestive Therapeutics (U.S.)
  • Sumitomo Dainippon Pharma Co. Ltd. (Japan)
  • IntelGenx Corp (Canada)
  • Wolters Kluwer (Netherlands)
  • XPhyto Pharma (Germany)
  • Other Prominent Players

Development of Cannabis-based Drugs to Propel Growth

The rising technological advancements occurring in the field of drug delivery systems is set to spur the thin film drugs market growth in the upcoming years. Additionally, numerous start-up firms are investing in the development of cannabis-based drugs. XPhyto Pharma, for instance, is likely to create around 13 drugs by using the thin firm drug delivery method. In Europe, the study is in Phase II clinical trial as of February 2021. However, the lack of high investments in emerging economies may obstruct growth.

Segmentation-

Retail Pharmacy Segment to Dominate Backed by Easy Availability of Drugs

Our analysts have segmented the market on the basis of product, disease indication, distribution channels, and geography. By product, it is fragmented into transdermal film drugs and oral thin film (OTF) drugs.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy Market Worldwide Growth, Industry Analysis, Regional Overview, Size and Share Forecast to 2028

  The global gene therapy market is likely to grow at an impressive CAGR over the forecast period, owing to recent technological advancements in gene replacement procedures. According to a report by Fortune Business Insights, titled ‘Gene Therapy: Global Market Analysis, Insights and Forecast, 2018 - 2025’ the market is likely to expand at a high rate due to increasing adoption of gene therapy in several countries across the world. For more information in the analysis of this report, visit:   https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243 Recently, there has been a growing emphasis on development of new gene replacement therapies. Encouraged by advancements in gene therapy and a high demand from end users, many companies are investing more in the research and development (R&D) of these products. According to Fortune Business Insights, in the coming years the market is likely to gain from the rising demand for gene therapy for haemophilia and oth
Read more

Spinal Fusion Devices Market Global Share, Growth, Outlook, Size, Opportunities, Trends, Regional Overview, and 2026

  The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run. Request a Sample Copy of the Market Research Report:   h
Read more

Biomaterials Market | Top 5 company Analysis Report : Before & After effect of covid 19 waves.

  The global “Biomaterials Market” is set to gain impetus from the increasing usage of a wide variety of biomaterials because of their clinical efficiencies. They also provide several benefits in wound healing applications. Fortune Business Insights™ published this information in a recent report, titled, “Biomaterials Market and Industry Analysis, By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers, and Natural Biomaterials), By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Urology, Gastroenterology, and Others), and Regional Forecast, 2020-2027.” Click here to get the short-term and long-term impact of COVID-19 on this Biomaterials Market. Please visit:  https://www.fortunebusinessinsights.com/biomaterials-market-102770 The report further mentions that the biomaterials market size was USD 110.0 billion in 2019 and is projected to reach USD 245.6 billion by 2027, thereby exhibiting a CAGR of 12.2% during the forecast period from 2020–2027. Segment- Me
Read more